Immunotherapy Outperforms Standard Therapy in Metastatic or Recurrent Cervical Cancer, Improving Survival
A groundbreaking study published in The Lancet has shown that incorporating immunotherapy into the first-line standard treatment for metastatic or recurrent cervical cancer significantly enhances …